Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus
Jul 9;
Non-conventional
in English
| Jul 9 | ID: covidwho-1309997
ABSTRACT
COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.
Search on Google
Collection:
Databases of international organizations
Database:
Jul 9
Type of study:
Observational study
/
Prognostic study
Language:
English
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS